Prot# CpG 7909 C016: Continuation Study of CPG 7909 in Patients w/Metastatic or Recurrent Malignancies Who Have Stable Disease or Who Have Responded to Therapy for their Malignancies & Have Completed a Previous Study of CPG 7909 as a Single Agent or in Co